Literature DB >> 10488782

Primary multidrug-resistant tuberculosis--Ivanovo Oblast, Russia, 1999.

.   

Abstract

The incidence of tuberculosis (TB) in the Russian Federation has increased steadily from 34 per 100,000 population in 1991 to 78 per 100,000 in 1998 (Central Tuberculosis Research Institute, unpublished data, 1999). To reverse this trend, in 1995, federal and local governments, with assistance from the World Health Organization (WHO), implemented a pilot project using the WHO TB-control strategy of directly observed therapy, short-course (DOTS) in Ivanovo oblast (1998 population: approximately 1.3 million), a district 165 miles (280 km) northeast of Moscow. This report documents a substantial increase in primary multidrug-resistant TB (P-MDRTB) in the civilian population of Ivanovo from January 1996 through October 1998 and a high prevalence of alcoholism, previous incarceration, unemployment, and history of homelessness among persons infected with both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.

Entities:  

Mesh:

Year:  1999        PMID: 10488782

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  6 in total

1.  Criteria for the control of drug-resistant tuberculosis.

Authors:  C Dye; B G Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Impact of DOTS and DOTS-plus on multidrug resistant TB: DOTS-plus strengthens, not weakens, DOTS programmes.

Authors:  Edward A Nardell
Journal:  BMJ       Date:  2003-07-19

Review 3.  Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.

Authors:  A Faustini; A J Hall; C A Perucci
Journal:  Thorax       Date:  2005-10-27       Impact factor: 9.139

4.  Prevalence and Determinants of Multidrug-Resistant Tuberculosis in Makkah, Saudi Arabia.

Authors:  Mohammad Fouad Mohammad Khatib Sambas; Unaib Rabbani; Manal Mansour Mezal Al-Gethamy; Saud Hasan Surbaya; Faisal Fuwaran Irmat Alharbi; Riyadh Ghazi Abdulrahman Ahmad; Hamzah Khalid Hamzah Qul; Safa Mohammed Saeed Nassar; Abdulaziz Khalid Mohammed Ali Maddah; Basel Ali Kabah Darweesh
Journal:  Infect Drug Resist       Date:  2020-11-10       Impact factor: 4.003

5.  Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?

Authors:  Claudia M Denkinger; Madhukar Pai; David W Dowdy
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

6.  Primary bacillary resistance in multidrug-resistant tuberculosis and predictive factors associated with cure at a referral center in São Paulo, Brazil.

Authors:  Marcia Telma Guimarães Savioli; Nelson Morrone; Ilka Santoro
Journal:  J Bras Pneumol       Date:  2019-03-11       Impact factor: 2.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.